Nukkleus receives Nasdaq notice for non-compliance with minimum market value

Nukkleus Inc. (NASDAQ:NUKK) disclosed that it received a notice from the Listing Qualifications Department of the Nasdaq Stock Market stating that the company no longer meets the minimum market value of listed securities required for continued listing on the Nasdaq Global Market. The notice was received on Thursday. According to InvestingPro data, the company’s market capitalization currently stands at approximately $39.7 million, with the stock experiencing a significant decline of about 87% year-to-date.

According to the company’s statement, Nasdaq determined that Nukkleus failed to maintain a market value of listed securities of at least $50 million for the 30 consecutive business days from July 10, 2025, to August 27, 2025, as required under Nasdaq Listing Rule 5450(b)(2)(A). The company also does not meet the requirements of Nasdaq Listing Rule 5450(b)(3)(A).

Nasdaq has given Nukkleus a compliance period of 180 calendar days, until February 24, 2026, to regain compliance. If at any point during this period the company’s market value of listed securities closes at or above $50 million for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance and close the matter. Nasdaq may require the company to maintain this threshold for more than ten but generally not more than twenty consecutive business days.

If Nukkleus does not regain compliance by the end of the compliance period, the company will receive written notification that its securities are subject to delisting from the Nasdaq Global Market. At that stage, Nukkleus may appeal the decision to a hearings panel or consider applying to transfer its listing to the Nasdaq Capital Market, provided it meets the requirements for that market.

The notice does not have an immediate effect on the listing or trading of Nukkleus’s common stock or warrants, which will continue to trade on the Nasdaq Global Market under the symbols NUKK and NUKKW, respectively, subject to continued compliance with other Nasdaq listing requirements.

Nukkleus stated it is monitoring its market value and considering options to regain compliance. The information is based on a press release statement included in the company’s filing with the Securities and Exchange Commission.

In other recent news, Nukkleus Inc. announced the formation of a strategic joint venture with Israeli firm Mandragola Ltd. to develop advanced manufacturing zones in the Baltics and Israel, targeting civil and defense aviation needs. The collaboration includes plans to establish a NATO-compliant logistics hub in Riga, Latvia, and facilities for licensed Maintenance, Repair, and Overhaul services, aircraft modernization, resale, and leasing. Additionally, Nukkleus has formed a new subsidiary, Nukkleus Defense Technologies Inc., to focus on defense activities and has secured an exclusive U.S. distribution agreement with BladeRanger Ltd. for drone payload systems.

The company also reported the transfer of a senior unsecured promissory note and a related stock purchase warrant to an unaffiliated third party, originally issued to East Asia Technology Investments Limited. Furthermore, Nukkleus has been added to the Russell Microcap Index, effective June 30, 2025, as part of the annual Russell indexes reconstitution. This inclusion reflects the company’s market capitalization ranking as of April 30. These developments highlight Nukkleus’ strategic moves within the aerospace and defense sectors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.